Venus Medtech (Hangzhou) VMTHF Stock
Venus Medtech (Hangzhou) Price Chart
Venus Medtech (Hangzhou) VMTHF Financial and Trading Overview
| Venus Medtech (Hangzhou) stock price | 0.42 USD |
| Previous Close | 0.42 USD |
| Open | 0.42 USD |
| Bid | 0.11 USD x 1000000 |
| Ask | 0.19 USD x 250000 |
| Day's Range | 0.42 - 0.42 USD |
| 52 Week Range | 0.27 - 0.52 USD |
| Volume | 1K USD |
| Avg. Volume | 0 USD |
| Market Cap | 186.06M USD |
| Beta (5Y Monthly) | 1.156 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.14 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VMTHF Valuation Measures
| Enterprise Value | 316.15M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.7292374 |
| Price/Book (mrq) | 0.704643 |
| Enterprise Value/Revenue | 1.239 |
| Enterprise Value/EBITDA | -0.98 |
Trading Information
Venus Medtech (Hangzhou) Stock Price History
| Beta (5Y Monthly) | 1.156 |
| 52-Week Change | -18.80% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 0.52 USD |
| 52 Week Low | 0.27 USD |
| 50-Day Moving Average | 0.42 USD |
| 200-Day Moving Average | 0.39 USD |
VMTHF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 441.01M |
| Float | 289.56M |
| Short Ratio | N/A |
| % Held by Insiders | 16.98% |
| % Held by Institutions | 18.80% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -181.94% |
| Operating Margin (ttm) | -125.89% |
| Gross Margin | 65.59% |
| EBITDA Margin | -126.43% |
Management Effectiveness
| Return on Assets (ttm) | -8.85% |
| Return on Equity (ttm) | -25.84% |
Income Statement
| Revenue (ttm) | 255.15M USD |
| Revenue Per Share (ttm) | 0.58 USD |
| Quarterly Revenue Growth (yoy) | -27.60% |
| Gross Profit (ttm) | 167.36M USD |
| EBITDA | -322588992 USD |
| Net Income Avi to Common (ttm) | -464228992 USD |
| Diluted EPS (ttm) | -0.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 71.29M USD |
| Total Cash Per Share (mrq) | 0.16 USD |
| Total Debt (mrq) | 202.69M USD |
| Total Debt/Equity (mrq) | 13.28 USD |
| Current Ratio (mrq) | 1.303 |
| Book Value Per Share (mrq) | 0.5987429 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Venus Medtech (Hangzhou)
| Country | United States |
| State | N/A |
| City | Hangzhou |
| Address | No. 88, Jiangling Road |
| ZIP | 310051 |
| Phone | N/A |
| Website | https://www.venusmedtech.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 557 |
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company's offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People's Republic of China.
Q&A For Venus Medtech (Hangzhou) Stock
What is a current VMTHF stock price?
Venus Medtech (Hangzhou) VMTHF stock price today per share is 0.42 USD.
How to purchase Venus Medtech (Hangzhou) stock?
You can buy VMTHF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Venus Medtech (Hangzhou)?
The stock symbol or ticker of Venus Medtech (Hangzhou) is VMTHF.
Which industry does the Venus Medtech (Hangzhou) company belong to?
The Venus Medtech (Hangzhou) industry is Medical Devices.
How many shares does Venus Medtech (Hangzhou) have in circulation?
The max supply of Venus Medtech (Hangzhou) shares is 441.01M.
What is Venus Medtech (Hangzhou) Price to Earnings Ratio (PE Ratio)?
Venus Medtech (Hangzhou) PE Ratio is now.
What was Venus Medtech (Hangzhou) earnings per share over the trailing 12 months (TTM)?
Venus Medtech (Hangzhou) EPS is -0.14 USD over the trailing 12 months.
Which sector does the Venus Medtech (Hangzhou) company belong to?
The Venus Medtech (Hangzhou) sector is Healthcare.
